Manufacturer of Controlled Substances Notice of Registration, 6062 [2010-2578]
Download as PDF
<![CDATA[
6062
Federal Register / Vol. 75, No. 24 / Friday, February 5, 2010 / Notices
aggregate national quota for Nabilone
established by DEA will not be affected
by this application of Kenco VPI since
the company imports Nabilone in
finished drug product form only.
DEA has considered the factors in 21
U.S.C. 823(a) and 952(a) and determined
that the registration of Kenco VPI to
import the basic class of controlled
substance is consistent with the public
interest, and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Kenco VPI to ensure that
the company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: January 29, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–2570 Filed 2–4–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Dated: January 27, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Drug Enforcement Administration
srobinson on DSKHWCL6B1PROD with NOTICES
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2), authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on April
3, 2009, Wildlife Laboratories, 1401 Duff
Drive, Suite 400, Fort Collins, Colorado
80524, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
Etorphine Hydrochloride (9059), a basic
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance for sale to its
customers.
VerDate Nov<24>2008
16:26 Feb 04, 2010
Jkt 220001
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic class of controlled substance
may file comments or objections to the
issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43,
and in such form as prescribed by 21
CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than March 8, 2010.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
[FR Doc. 2010–2575 Filed 2–4–10; 8:45 am]
BILLING CODE 4410–09–P
Drug
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Cocaine (9041) .............................
Schedule
I
I
I
The Institute will manufacture small
quantities of cocaine and marihuana
derivatives for use by their customers in
analytical kits, reagents, and reference
standards as directed by the National
Institute on Drug Abuse.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Research Triangle Institute to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Research Triangle Institute
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: January 25, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–2578 Filed 2–4–10; 8:45 am]
BILLING CODE 4410–09–P
MARINE MAMMAL COMMISSION
Notice of Meeting
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Registration
By Notice dated August 21, 2009, and
published in the Federal Register on
September 8, 2009, (74 FR 46232),
Research Triangle Institute, Kenneth H.
Davis Jr., Hermann Building, East
Institute Drive, P.O. Box 12194,
Research Triangle, North Carolina
27709, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
PO 00000
Frm 00123
Fmt 4703
Sfmt 4703
Time and Date: The Marine Mammal
Commission will conduct a review of
the potential effects of human activities,
including aquaculture operations, on
harbor seals in Drake’s Estero, Mann
County, California, on 21–24 February
2010 from 9 a.m. to approximately 6
p.m.
Place: The Red Barn, Point Reyes
National Seashore, I Bear Valley Road,
Point Reyes Station, CA 94956.
Status: Sessions on Sunday, February
21, and Tuesday and Wednesday,
February 23–24 will be open to the
public. Public participation will be
allowed as time permits and as
determined to be desirable by the
meeting chairperson. There will be no
public meeting on Monday, February
22.
E:\FR\FM\05FEN1.SGM
05FEN1
]]>Agencies
[Federal Register Volume 75, Number 24 (Friday, February 5, 2010)]
[Notices]
[Page 6062]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2578]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances Notice of Registration
By Notice dated August 21, 2009, and published in the Federal
Register on September 8, 2009, (74 FR 46232), Research Triangle
Institute, Kenneth H. Davis Jr., Hermann Building, East Institute
Drive, P.O. Box 12194, Research Triangle, North Carolina 27709, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Cocaine (9041)............................. I
------------------------------------------------------------------------
The Institute will manufacture small quantities of cocaine and
marihuana derivatives for use by their customers in analytical kits,
reagents, and reference standards as directed by the National Institute
on Drug Abuse.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Research Triangle Institute to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Research Triangle Institute to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: January 25, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-2578 Filed 2-4-10; 8:45 am]
BILLING CODE 4410-09-P
